Vaccine News and Research

Latest Vaccine News and Research

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Study shows parental hesitancy to begin and complete child's HPV vaccine series

Study results documenting parental hesitancy to begin and complete their child's HPV vaccine series were published in The Lancet Public Health by researchers at The University of Texas Health Science Center at Houston.

22 Jul 2020

Scientists want to know more about using UV light to fight COVID-19 spread

High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.

22 Jul 2020

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.

22 Jul 2020

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.

22 Jul 2020

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Thermo Fisher Scientific Inc., the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally.

From Thermo Fisher Scientific Inc. 22 Jul 2020

Survey: Almost 60% of parents are reluctant to protect their children from HPV

22 Jul 2020

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Scientists report two new cryo-EM structures representing the pre- and postfusion conformations of the full-length SARS-CoV-2 spike (S) protein, an essential viral component responsible for host cell entry and the spread of infection.

22 Jul 2020

Study captures unexpected features of SARS-Cov-2 spike protein

The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic.

22 Jul 2020

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions.

21 Jul 2020

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Now, a new study published on the preprint server bioRxiv in July 2020 presents an engineered transgenic mouse that reproduces the functional and clinical characteristics of severe human SARS-CoV-2 infection.

21 Jul 2020

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

A new study published on the preprint server medRxiv by a research group from the U.S. and Germany indicates that a novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) induces functional and proinflammatory T cell responses in almost all participants – marking another landmark achievement for this promising vaccine candidate.

21 Jul 2020

Nitric oxide treatment can be pivotal in the fight against COVID-19

Nitric oxide treatment can be pivotal in the world's fight against SARS-CoV-2, the coronavirus that causes COVID-19, according to a review from the George Washington University (GW). The article is published in the journal Nitric Oxide.

21 Jul 2020

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

Sanford Burnham Prebys Medical Discovery Institute has received an award from the California Institute for Regenerative Medicine to advance promising drug candidates for COVID-19.

21 Jul 2020

New tools developed to test the ability of anti-coronavirus antibodies

Researchers at The Rockefeller University in New York have developed new tools to rapidly test the ability of antibodies to neutralize SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic.

21 Jul 2020

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

With experts stating that 120,000 people could perish from Coronavirus in the closing months of the year, a health charity is warning Britain had better brace itself for another crisis – antibiotic resistant infections.

21 Jul 2020

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.

21 Jul 2020

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

China is among the leading countries that are aggressively involved in developing vaccines for COVID-19, with one vaccine each from Sinopharm Group and Sinovac Biotech entering Phase 3 clinical development.

21 Jul 2020

Analysis of the SARS-CoV-2 proteome via visual tools

Now, a new study published on the preprint server bioRxiv* in July 2020 shows how this can be advanced at a greater speed by combining experimental results with homology models obtained by high-throughput pipelines. This will help produce new hypotheses that will show novel druggable targets for effective drug development.

21 Jul 2020

Doctor in Israel reinfected with COVID-19 three months after recovering

There is still a lot to learn about coronavirus disease (COVID-19), which is currently ravaging across the globe. Though scientists are slowly gaining a better understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is still unclear if being infected once may provide long-lasting immunity against the novel coronavirus.

20 Jul 2020

Vaccine News and Research

Latest Vaccine News and Research

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Study shows parental hesitancy to begin and complete child's HPV vaccine series

Scientists want to know more about using UV light to fight COVID-19 spread

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Survey: Almost 60% of parents are reluctant to protect their children from HPV

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Study captures unexpected features of SARS-Cov-2 spike protein

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Nitric oxide treatment can be pivotal in the fight against COVID-19

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

New tools developed to test the ability of anti-coronavirus antibodies

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

Analysis of the SARS-CoV-2 proteome via visual tools

Doctor in Israel reinfected with COVID-19 three months after recovering

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in